These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10084154)

  • 41. A glycoprotein from a folk medicinal plant, Withania somnifera, inhibits hyaluronidase activity of snake venoms.
    Machiah DK; Girish KS; Gowda TV
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Jun; 143(2):158-61. PubMed ID: 16513428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The effect of calmodulin and chlorpromazine on the activity of phospholipases A2 from various sources].
    Azizova NN; Muratova UZ; Gagel'gans AI; Saatov TS
    Biokhimiia; 1990 Jan; 55(1):23-8. PubMed ID: 2344456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Russell's viper venom fractions on systemic and renal hemodynamics.
    Suwansrinon K; Khow O; Mitmoonpitak C; Daviratanasilpa S; Chaiyabutr N; Sitprija V
    Toxicon; 2007 Jan; 49(1):82-8. PubMed ID: 17078988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines that Targets Snake Venom Phospholipase A2.
    Anilkumar NC; Sundaram MS; Mohan CD; Rangappa S; Bulusu KC; Fuchs JE; Girish KS; Bender A; Basappa ; Rangappa KS
    PLoS One; 2015; 10(7):e0131896. PubMed ID: 26196520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular dynamics study of secretory phospholipase A2 of Russell's viper and bovine pancreatic sources.
    Ramakrishnan C; Subramanian V; Velmurugan D
    J Phys Chem B; 2010 Oct; 114(42):13463-72. PubMed ID: 20923223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumour necrosis factor (TNF) in Russell's viper envenomation.
    Jayasinghe KS; Ariaratnam A
    Ceylon Med J; 1994 Jun; 39(2):112-3. PubMed ID: 7923450
    [No Abstract]   [Full Text] [Related]  

  • 47. Simultaneous inhibition of anti-coagulation and inflammation: crystal structure of phospholipase A2 complexed with indomethacin at 1.4 A resolution reveals the presence of the new common ligand-binding site.
    Singh N; Kumar RP; Kumar S; Sharma S; Mir R; Kaur P; Srinivasan A; Singh TP
    J Mol Recognit; 2009; 22(6):437-45. PubMed ID: 19462410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute pituitary insufficiency and hypokalaemia following envenoming by Russell's viper (Daboia russelii) in Sri Lanka: Exploring the pathophysiological mechanisms.
    Jeevagan V; Katulanda P; Gnanathasan CA; Warrell DA
    Toxicon; 2013 Mar; 63():78-82. PubMed ID: 23212048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SB-253514 and analogues: novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. II. Physico-chemical properties and structure elucidation.
    Busby DJ; Copley RC; Hueso JA; Readshaw SA; Rivera A
    J Antibiot (Tokyo); 2000 Jul; 53(7):670-6. PubMed ID: 10994808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2.
    Boyd HF; Hammond B; Hickey DM; Ife RJ; Leach CA; Lewis VA; Macphee CH; Milliner KJ; Pinto IL; Smith SA; Stansfield IG; Theobald CJ; Whittaker CM
    Bioorg Med Chem Lett; 2001 Mar; 11(5):701-4. PubMed ID: 11266173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2.
    Boyd HF; Fell SC; Flynn ST; Hickey DM; Ife RJ; Leach CA; Macphee CH; Milliner KJ; Moores KE; Pinto IL; Porter RA; Rawlings DA; Smith SA; Stansfield IG; Tew DG; Theobald CJ; Whittaker CM
    Bioorg Med Chem Lett; 2000 Nov; 10(22):2557-61. PubMed ID: 11086729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Total syntheses of (+)- and (-)-cacospongionolide B, cacospongionolide e, and related analogues. Preliminary study of structural features required for phospholipase a2 inhibition.
    Cheung AK; Murelli R; Snapper ML
    J Org Chem; 2004 Aug; 69(17):5712-9. PubMed ID: 15307744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors.
    Muller P; Lena G; Boilard E; Bezzine S; Lambeau G; Guichard G; Rognan D
    J Med Chem; 2006 Nov; 49(23):6768-78. PubMed ID: 17154507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enantiospecific synthesis of the phospholipase A2 inhibitors (-)-cinatrin C1 and (+)-cinatrin C3.
    Cuzzupe AN; Di Florio R; White JM; Rizzacasa MA
    Org Biomol Chem; 2003 Oct; 1(20):3572-7. PubMed ID: 14599020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel 2-oxoamide inhibitors of human group IVA phospholipase A(2).
    Kokotos G; Kotsovolou S; Six DA; Constantinou-Kokotou V; Beltzner CC; Dennis EA
    J Med Chem; 2002 Jul; 45(14):2891-3. PubMed ID: 12086476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New weapons against inflammation: dual inhibitors of phospholipase A2 and transglutaminase.
    Miele L
    J Clin Invest; 2003 Jan; 111(1):19-21. PubMed ID: 12511581
    [No Abstract]   [Full Text] [Related]  

  • 57. Synthesis and properties of novel lipopeptides and lipid mimetics.
    Nicolaou A; Kokotos G; Constantinou-Kokotou V; Charitos C; Noula C; Verger R; Gibbons WA
    J Pept Sci; 1997; 3(4):291-8. PubMed ID: 9262648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and biological evaluation of 4-(4-(alkyl- and phenylaminocarbonyl)benzoyl)benzoic acid derivatives as non-steroidal inhibitors of steroid 5 alpha-reductase isozymes 1 and 2.
    Salem OI; Schulz T; Hartmann RW
    Arch Pharm (Weinheim); 2002 Mar; 335(2-3):83-8. PubMed ID: 12043459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. WA8242A1, A2 and B, novel secretory phospholipase A2 inhibitors produced by Streptomyces violaceusniger. I. Taxonomy, production and purification.
    Yoshimura S; Otsuka T; Tsurumi Y; Muramatsu Y; Hatanaka H; Okamoto M; Hashimoto S; Okuhara M
    J Antibiot (Tokyo); 1998 Jan; 51(1):1-7. PubMed ID: 9531980
    [No Abstract]   [Full Text] [Related]  

  • 60. Enantiospecific synthesis and in vitro activity of selective inhibitors of rat brain kynureninase and kynurenine-3-hydroxylase.
    Giordani A; Corti L; Cini M; Bormetti R; Marconi M; Veneroni O; Speciale C; Varasi M
    Adv Exp Med Biol; 1996; 398():531-4. PubMed ID: 8906317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.